Omeq Medical

Omeq Medical

VP R&D Oded Tsamir (front) and CEO Lior Margalit (back) of Omeq Medical

The Need

The epidural space has been termed an anatomical labyrinth. This very narrow space (only 5 millimeters wide) surrounding the spinal cord contains spinal nerve roots, loose fatty tissue, and blood vessels. Drugs injected into the epidural space (“epidurals”) are used for anesthesia and analgesic purposes during and after surgery.

Locating the epidural space requires careful insertion and advancement of a needle into the middle or lower back. Many anesthesiologists today use the loss of resistance (LoR) technique to confirm correct needle placement. Administering epidural injections requires extensive training and relies heavily on feel. Inaccurate needle placement occurs in up to 12% of cases, resulting in ineffective drug delivery and complications such as severe headaches or nerve damage.

To optimize epidural anesthesia and analgesia, the market seeks an objective method for detecting correct needle placement within the epidural space.

The Product

Omeq Medical is developing a sensor-based epidural placement system for safe, accurate epidural injections. The system gives automatic audio and video signals to indicate correct needle placement.

The Advantages

  • Real-time, objective detection of the epidural space
  • Improved analgesia/anesthesia success rate
  • Reduced needle placement complications
  • Used in conjunction with the LoR technique

 The Team

  • Lior Margalit, CEO: Previously, R&D and QA engineer, EndyMed, a medical device start-up; naval officer and captain, Israeli Navy; B.Sc.,biomedical engineering, Ben-Gurion University of the Negev
  • Oded Tsamir, VP R&D: Previously, R&D engineer, Smart Medical System; IP manager, Solomon’s Seal; B.Sc., biomedical engineering, Ben-Gurion University of the Negev
  • Daniel Levin, Ph.D., Business Advisor: Over 40 years’ experience in R&D and business management; CEO and founder of CoreFlow; Ph.D., aeronautical engineering, Technion-Israel Institute of Technology
  • Prof. Elon Eisenberg, Medical Advisor: Director of the Institute of Pain Medicine, Rambam Health Care Campus; Associate Professor of Neurology and Pain Medicine, Faculty of Medicine, Technion-Israel Institute of Technology; M.D., Sackler School of Medicine, Tel Aviv University; published over 150 articles and book chapters
  • David Gichtin, M.D., Medical Advisor: Clinical Associate, Department of Anesthesiology and Critical Care Medicine, Johns Hopkins Medicine Bayview Medical Center; anesthesiologist, Baltimore Pain Management Center; M.D., University of Kentucky College of Medicine; member of American Board of Anesthesiology and American Society of Pain Management

The Market

In the United States, over 20 million epidural injections are given annually, with an additional 19 million injections in the rest of the world. Industry leaders B. Braun, Becton Dickinson, and Portex control this $600 million global market with standard epidural kits.

medical_omeq
Sensor-based epidural needle placement system

At a Glance

Stage: Technology development
Founded: April 2013
Investor: The Trendlines Group
IP: Patent in National phase

In the Media

Named one of "6 captivating start-ups of 2013" (Globes)

Contact

Lior Margalit, CEO
Mobile: +972.54.431.5304
lior@omeqmedical.com
www.omeqmedical.com